Fiera Capital (Canada)’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
ACA
RG
PAI
Fiera Capital (Canada)'s FOLD Position: Q1 2025 in Review
Fiera Capital (Canada) sold out of Amicus Therapeutics (FOLD) in Q1 2025, closing a stake of 3,037,248 shares — an estimated $28.6M sold.
Fiera Capital (Canada) first reported a position in FOLD in Q1 2021 and held it in 16 quarters. The position peaked at $71.8M in Q4 2023. 286 funds tracked by Wall St. Rank hold FOLD as of Q1 2025.
- Fiera Capital (Canada) reported no remaining Amicus Therapeutics position as of Q1 2025 after selling out during the quarter.
- Fiera Capital (Canada) sold 3,037,248 Amicus Therapeutics shares in Q1 2025, an estimated $28.6M.
- Fiera Capital (Canada) first reported a position in Amicus Therapeutics in Q1 2021 and held it in 16 quarters.
- Fiera Capital (Canada)'s Amicus Therapeutics position peaked at $71.8M in Q4 2023.
- 286 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2025.
Based on Fiera Capital (Canada)'s 13F filing for Q1 2025, filed 7 May 2025.